Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin vs Clonidine for Hot Flashes in Breast Cancer
NCT01530373Phase 2Recruiting
- Sponsor
- University of Arkansas
- Start
- Feb 2012
- Primary completion
- Jul 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of solifenacin in hot flashes, sponsored by University of Arkansas. Started Feb 2012; status: recruiting.
02
Drugs
solifenacin
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT01530373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01530373.